Advertisement

Squamous Cell Carcinoma

  • Anna Belloni Fortina
  • Stefano Piaserico
  • Mauro Alaibac
  • Andrea Peserico
Part of the Cancer Treatment and Research book series (CTAR, volume 146)

During the past years, solid organ transplantations have been performed with increasing success. The long-term survival of organ transplantation is related particularly on the prevention of allograft rejection. Various regimens have been utilised to suppress the host immune response to the transplanted organs. It has been well demonstrated that a relationship exists between immunosuppression and the risk of different malignancies in organ transplant recipients (OTRs). Moreover, patients who have received solid organ transplants are known to have increased susceptibility of developing skin cancer as a result of the intense immunosuppressive regimens. In particular, transplant recipients have a significantly increased risk of developing squamous cell carcinoma (SCC).

Keywords

Squamous Cell Carcinoma Transplant Recipient Skin Cancer Human Papilloma Virus Basal Cell Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

  1. 1.
    Jensen P, Hansen S, Moller B, Leivestad T, Pfeffer P, Geiran O, Fauchald P, Simonsen S. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40:177–186.PubMedCrossRefGoogle Scholar
  2. 2.
    Bouwes Bavinck JN, Hardie DR, Green A, Cutmore S, MacNaught A, O’Sullivan B,Siskind V, van der Woude FJ, Hardie IR. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation 1996; 61:715–721.Google Scholar
  3. 3.
    Fuente MJ, Sabat M, Roca J, Lauzurica R, Fernandez-Figueras MT, Ferrandiz C. A prospective study of the incidence of skin cancer and its risk factors in a Spanish Mediterranean population of kidney transplant recipients. Br J Dermatol 2003; 149:1221–1226.PubMedCrossRefGoogle Scholar
  4. 4.
    Belloni Fortina A, Piaserico S, Caforio ALP, Abeni D, Alaibac M, Angelini A, Iliceto S, Peserico A. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. Arch Dermatol 2004; 140:1079–1085.CrossRefGoogle Scholar
  5. 5.
    Hartevelt MM, Bouwes Bavinck JN, Kootte AMM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990; 49:506–509.PubMedCrossRefGoogle Scholar
  6. 6.
    Euvrard S, Kanitakis J, Decullier E, Butnaru AC, Lefrançois N, Boissonnat P, Sebbag L, Garnier JL, Pouteil-Noble C, Cahen R, Morelon E, Touraine JL, Claudy A, Chapuis F. Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma. Transplantation 2006; 81:1093–1100.PubMedCrossRefGoogle Scholar
  7. 7.
    Moloney FJ, Comber H, O’Lorcain P, O’Kelly P, Conlon PJ, Murphy GM. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006; 154:498–504.PubMedCrossRefGoogle Scholar
  8. 8.
    Caforio ALP, Belloni Fortina A, Piaserico S, et al. Skin cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy. Circulation 2000; 102(Suppl III):222–227.Google Scholar
  9. 9.
    Pfeifer GP, You YH, Besaratinia A. Mutuations induced by ultraviolet light. Mutat Res 2005; 571:19–31.PubMedGoogle Scholar
  10. 10.
    Ullrich SE. Mechanisms underlying UV-induced immune suppression. Mutat Res 2005; 571:185–205.PubMedGoogle Scholar
  11. 11.
    McLelland J, Rees A, Williams G, Chu T. The incidence of immunosuppression-related skin disease in long-term transplant patients. Transplantation 1988; 46:871–874.PubMedCrossRefGoogle Scholar
  12. 12.
    Bouwes Bavinck JN, Vermeer BJ, van der Woude FJ, Vandenbroucke JP, Schreuder GM, Thorogood J, Persijn GG, Claas FHJ. Relations between skin cancer and HLA antigens in renal-transplant recipients. N Engl J Med 1991; 325:843–848.PubMedCrossRefGoogle Scholar
  13. 13.
    Roeger LS, Sheil AGR, Disney APS, Mathew TH, Amiss N. Risk factors associated with the development of squamous cell carcinoma in immunosuppressed renal transplant recipients. Clin Transplant 1992; 6:202–211.Google Scholar
  14. 14.
    Ferràndiz C, Fuente MJ, Ribera M, Bielsa I, Fernandez MT, Lauzurica R, Roca J. Epidermal dysplasia and neoplasia in kidney transplant recipients. J Am Acad Dermatol 1995; 33:590–596.PubMedCrossRefGoogle Scholar
  15. 15.
    Bouwes Bavinck JN, De Boer A, Vermeer BJ, Hartevelt MM, Van Der Woude FJ, Claas FHJ, Wolterbeek R, Vandenbroucke JP. Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients. Br J Dermatol 1993; 129:242–249.CrossRefGoogle Scholar
  16. 16.
    Boukamp P. Non-melanoma skin cancer: what drivers tumor development and progression? Carcinogenesis 2005; 26:1657–1667.PubMedCrossRefGoogle Scholar
  17. 17.
    Walder BK, Robertson MR, Jeremy D. Skin cancer and immunosuppression. Lancet 1971; 2:1282–1283.PubMedCrossRefGoogle Scholar
  18. 18.
    Ramsay HM, Fryer AA, Reece S, Smith AG, Harden PN. Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis 2000; 36:167–176.PubMedCrossRefGoogle Scholar
  19. 19.
    Harwood CA, Surentheran T, McGregor JM, et al. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000; 61:289–297.PubMedCrossRefGoogle Scholar
  20. 20.
    Forslund O, Ly H, Reid C, Higgins G. A broad spectrum of human papillomavirus types is present in the skin of Australian patients with non-melanoma skin cancers and solar keratosis. Br J Dermatol 2003; 149:64–73.PubMedCrossRefGoogle Scholar
  21. 21.
    Meyer T, Arndt R, Nindl I, Ulrich C, Christophers E, Stockfleth E. Association of human papillomavirus infections with cutaneous tumors in immunosuppressed patients. Transplant Int 2003; 16:146–153.CrossRefGoogle Scholar
  22. 22.
    Shamanin V, zur Hausen H, Lavergne D, Proby CM, Leigh IM, Neumann C, Hamm H, Goos M, Haustein UF, Jung EG, Plewig G, Wolff H, de Villiers EM. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst 1996; 88:802–811.PubMedCrossRefGoogle Scholar
  23. 23.
    Dong W, Kloz U, Accardi R, Caldeira S, Tong WM, Wang ZQ, Jansen L, Durst M, Sylla BS, Gissmann L, Tommasino M. Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type 38. J Virol 2005; 79:14899–14908.PubMedCrossRefGoogle Scholar
  24. 24.
    Espana A, Martinez-Gonzalez MA, Garcia-Granero M, Sanchez-Carpintero I, Rabago G, Herreros J. A prospective study of incident nonmelanoma skin cancer in heart transplant recipients. J Invest Dermatol 2000; 115:1158–1160.PubMedCrossRefGoogle Scholar
  25. 25.
    Ferràndiz C, Fuente MJ, Ribera M, Bielsa I, Fernandez MT, Lauzurica R, Roca J. Epidermal dysplasia and neoplasia in kidney transplant recipients. J Am Acad Dermatol 1995; 33:590–596.PubMedCrossRefGoogle Scholar
  26. 26.
    Boxman IL, Berkhout RJ, Mulder LH, Wolkers MC, Bouwes Bavinck JN, Vermeer BJ, ter Schegget J. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol 1997; 108:712–715.PubMedCrossRefGoogle Scholar
  27. 27.
    Antonsson A, Forslund O, Ekberg H, Sterner G, Hansson BG. The ubiquity and impressive genomic diversity of human skin papillomavirus suggest a commensalic nature of these viruses. J Virol 2000; 74:11636–11641.PubMedCrossRefGoogle Scholar
  28. 28.
    Astori G, Lavergne D, Benton C, Hockmayr B, Egawa K, Garbe C, de Villiers EM. Human papillomavirus are commonly found in normal skin of immunocompetent hosts. J Invest Dermatol 1998; 110:752–755.PubMedCrossRefGoogle Scholar
  29. 29.
    Ramsay HM, Fryer AA, Hawley CM, Smith AG, Nicol DL, Harden PN. Factors associated with nonmelanoma skin cancer following renal transplantation in Queensland, Australia. J Am Acad Dermatol 2003; 49:397–406.PubMedCrossRefGoogle Scholar
  30. 30.
    Ong CS, Keogh AM, Kossard S, Macdonald PS, Spratt PM. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999; 40:27–34.PubMedCrossRefGoogle Scholar
  31. 31.
    Bordea C, Wojnarowska F, Millard PR, Doll H, Welsh K, Morris PJ. Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation 2004; 77:574–579.PubMedCrossRefGoogle Scholar
  32. 32.
    Herrero JI, España A, Quiroga J, Sangro B, Pardo F, Alvárez-Cienfuegos J, Prieto J. Nonmelanoma skin cancer after liver transplantation. Study of risk factors. Liver Transplant 2005; 11:1100–1106.CrossRefGoogle Scholar
  33. 33.
    Roeger LS, Sheil AGR, Disney APS, Mathew TH, Amiss N. Risk factors associated with the development of squamous cell carcinoma in immunosuppressed renal transplant recipients. Clin Transplant 1992; 6:202–211.Google Scholar
  34. 34.
    Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348:1681–1691.PubMedCrossRefGoogle Scholar
  35. 35.
    Otley CC, Cherikh WS, Salasche SJ, McBride MA, Christenson LJ, Kauffmann HM. Skin cancer in organ transplant recipients: effect of pretransplant end-organ disease. J Am Acad Dermatol 2005; 53:783–790.PubMedCrossRefGoogle Scholar
  36. 36.
    Naldi L, Belloni Fortina A, Lovati S, Barba A, Gotti E, Tessari G, Schena D, Diociaiuti A, Nanni G, La Parola IL, Masini C, Piaserico S, Peserico A, Cainelli T, Remuzzi G. Risk of nonmelanoma skin cancer in Italian organ transplant recipients. Registry-based study. Transplantation 2000; 70:1479–1484Google Scholar
  37. 37.
    Moosa MR, Gralla J. Skin cancer in renal allograft recipients: experience in different ethnic groups residing in the same geographical region. Clin Transplant 2005; 19:735–741.PubMedGoogle Scholar
  38. 38.
    Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4:905–913.PubMedCrossRefGoogle Scholar
  39. 39.
    Bock A, Bliss RL, Matas A, Little JA. Human leukocyte antigen type as a risk factor for nonmelanomatous skin cancer in patients after renal transplantation. Transplantation 2004; 78:775–778.PubMedCrossRefGoogle Scholar
  40. 40.
    Bouwes Bavinck JN, Kootte AM, Van Der Woude FJ, et al. On a possible protective effect of HLA-A11 against skin cancer and keratotic skin lesions in renal transplant recipients. J Invest Dermatol 1991; 97:269.PubMedCrossRefGoogle Scholar
  41. 41.
    Dyall-Smith D, Ross JB. Cutaneous malignancies in renal transplant recipients from Nova Scotia, Canada. Aust J Dermatol 1995; 36:79.CrossRefGoogle Scholar
  42. 42.
    McGregor JM, Harwood CA, Brooks L, et al. Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer. J Invest Dermatol 2002; 119:84–90.PubMedCrossRefGoogle Scholar
  43. 43.
    Cairey-Remonnay S, Humbey O, Mougin C, et al. TP53 polymorphism of exon 4 at codon 72 in cutaneous squamous cell carcinoma and benign epithelial lesions of renal transplant recipients and immunocompetent individuals: lack of correlation with human papillomavirus status. J Invest Dermatol 2002; 118:1026–1031.PubMedCrossRefGoogle Scholar
  44. 44.
    O’Connor DP, Kay EW, Leader M, Atkins GJ, Murphy GM, Mabruk MJEMF. p53 codon 72 polymorphism and human papillomavirus associated skin cancer. J Clin Pathol 2001; 54:539–542.PubMedCrossRefGoogle Scholar
  45. 45.
    Marshall SE, Bordea C, Wojnarowska F, Morris PJ, Welsh KI. p53 codon 72 polymorphism and susceptibility to skin cancer after renal transplantation. Transplantation 2000; 69:994–996.PubMedCrossRefGoogle Scholar
  46. 46.
    Alamartine E, Berthoux P, Mariat C, Cambazard F, Berthoux F. Interleukin-10 promoter polymorphisms and susceptibility to skin squamous cell carcinoma after renal transplantation. J Invest Dermatol 2003; 120:99–103.PubMedCrossRefGoogle Scholar
  47. 47.
    Lira MG, Provezza L, Malerba G, Naldi L, Remuzzi G, Boschiero L, Forni A, Rugiu C, Piaserico S, Alaibac M, Turco A, Girolomoni G, Tessari G. Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients. Exp Dermatol 2006; 15:958–965.PubMedCrossRefGoogle Scholar
  48. 48.
    Ramsay HM, Harden RN, Reece S, et al. Polymorphism in glutathione S-transferases are associated with altered risk of nonmelanoma skin cancer in renal transplant recipients: a preliminary analysis. J Invest Dermatol 2001; 117:251–255.PubMedCrossRefGoogle Scholar
  49. 49.
    Fryer AA, Ramsey HM, Lovatt TJ, Jones PW, Hawley CM, Nicol DL, Strange RC, Harden PN. Polymorphisms in glutathione S-transferase and non-melanoma skin cancer risk in Australian renal transplant recipients. Carcinogenesis 2005; 26:185–191.PubMedCrossRefGoogle Scholar
  50. 50.
    Marshall SE, Bordea C, Haldar N, et al. Glutathione S-transferase polymorphisms and skin cancer after renal transplantation. Kidney Int 2000; 58:2186–2193.PubMedCrossRefGoogle Scholar
  51. 51.
    Otley CC, Coldiron BM, Stasko T, Goldman GD. Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants. Arch Dermatol 2001; 137:459–463.PubMedGoogle Scholar
  52. 52.
    London NJ, Farmery SM, Will EJ, Davison AM, Lodge JP. Risk of neoplasia in renal transplant patients. Lancet 1995; 346:403–406.PubMedCrossRefGoogle Scholar
  53. 53.
    Glover MT, Deeks JJ, Raftery MJ, Cunnigham J, Leigh IM. Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients. Lancet 1997; 349:398.PubMedCrossRefGoogle Scholar
  54. 54.
    Dantal J, Hourmant M, Cantarovich D, Giral M, Blancho G, Dreno B. Effects of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 1998; 351:623–628.PubMedCrossRefGoogle Scholar
  55. 55.
    Ducloux D, Carron PL, Rebibou JM, Aubin F, Fournier V, Bresson-Vautrin C, Blanc D, Humbert P, Chalopin JM. CD4 lymphocytopenia as a risk factor for skin cancers in renal transplant recipients. Transplantation 1998; 65:1270–1272.PubMedCrossRefGoogle Scholar
  56. 56.
    Swann PF, Waters TR, Moulton DC, et al. Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine. Science 1996; 273:1109.PubMedCrossRefGoogle Scholar
  57. 57.
    O’Donovan P, Perret CM, Zhang X, Montaner B, Xu YZ, Harwood CA, McGregor JM, Walker SL, Hanaoka F, Karran P. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 2005; 309:1871–1874.PubMedCrossRefGoogle Scholar
  58. 58.
    Hojo M, Morimoto T, Maluccio M, et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999; 397:530.PubMedCrossRefGoogle Scholar
  59. 59.
    Yarosh DB, Pena AV, Nay SL, Canning MT, Brown DA. Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation. J Invest Dermatol 2005; 125:1020–1025.PubMedCrossRefGoogle Scholar
  60. 60.
    Maluccio M, Sharma V, Lagman M, et al. Tacrolimus enhances transforming growth factor-beta expression and promotes tumor progression. Transplantation 2003; 76:597.PubMedCrossRefGoogle Scholar
  61. 61.
    Sakai M, Miyake H, Tashiro S, et al. Inhibitory effects of FK506 and cyclosporine A on the growth and invasion of human liver cancer cells. J Med Invest 2004; 51:63.PubMedCrossRefGoogle Scholar
  62. 62.
    Belloni Fortina A, Caforio ALP, Piaserico S, et al. Skin cancer in heart transplant recipients: frequency and risk factor analysis. J Heart Lung Transplant 2000; 19:249–255.CrossRefGoogle Scholar
  63. 63.
    Euvrard S, Kanitakis J, Pouteil-Noble C, et al. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dematol 1995; 33:222–229.CrossRefGoogle Scholar
  64. 64.
    Mithoefer AB, Supran S, Freeman RB. Risk factors associated with the development of skin cancer after liver transplantation. Liver Transplant 2002; 8:939–944.CrossRefGoogle Scholar
  65. 65.
    Rook AH, Shapiro M. Cutaneous squamous-cell carcinoma. N Engl J Med 2001; 345:296.PubMedCrossRefGoogle Scholar
  66. 66.
    Euvrard S, Kanitakis J, Pouteil-Noble C, Euvrard S, Kanitakis J, Pouteil-Noble C, Disant F, Dureau G, Finaz de Villaine J, Claudy A, Thivolet J. Aggressive squamous cell carcinomas in organ transplant recipients. Transplant Proc 1995; 27:1767–1768.PubMedGoogle Scholar
  67. 67.
    Leigh IM, Glover MT. Skin cancer and warts in immunosuppressed renal transplant recipients. Recent Results Cancer Res 1995; 139:69–86.PubMedGoogle Scholar
  68. 68.
    Webb MC, Compton F, Andrews PA, Koffman CG. Skin tumours posttransplantation: retrospective analysis of 28 years’ experience at a single centre. Transplant Proc 1997; 29:828–830.PubMedCrossRefGoogle Scholar
  69. 69.
    Winkelhorst JT, Brokelman WJ, Tiggeler RG, Wobbes T. Incidence and clinical course of de-novo malignancies in renal allograft recipients. Eur J Surg Oncol 2001; 27:409–413.PubMedCrossRefGoogle Scholar
  70. 70.
    Stockfleth E, Ulrich C, Meyer T, Christophers E. Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment. Recent Results Cancer Res 2002; 160:251–258.PubMedGoogle Scholar
  71. 71.
    Cooper JZ, Brown MD. Special concern about squamous cell carcinoma of the scalp in organ transplant recipients. Arch Dermatol 2006; 142:755–758.PubMedCrossRefGoogle Scholar
  72. 72.
    Lindelof B, Dal H, Wolk K, Malmborg N. Cutaneous squamous cell carcinoma in organ transplant recipients: a study of the Swedish Cohort with regard to tumor site. Arch Dermatol 2005; 141:447–451.PubMedCrossRefGoogle Scholar
  73. 73.
    Carucci JA. Squamous cell carcinoma in organ transplant recipients: approach to management. Skin Therapy Lett 2004; 9:5–7.PubMedGoogle Scholar
  74. 74.
    Carucci JA. Cutaneous oncology in organ transplant recipients: meeting the challenge of squamous cell carcinoma. J Invest Dermatol 2004; 123:809–816.PubMedCrossRefGoogle Scholar
  75. 75.
    Petter G, Haustein UF. Histologic subtyping and malignancy assessment of cutaneous squamous cell carcinoma. Dermatol Surg 2000; 26:521–530.PubMedCrossRefGoogle Scholar
  76. 76.
    Glover M, Cerio R, Corbett M, Leigh I, Hanby AM. Cutaneous squamoproliferative lesions in renal transplant recipients. Differentiation from lesions in immunocompetent patients. Am J Dermatopathol 1995; 17:551–554.Google Scholar
  77. 77.
    Smith KJ, Hamza S, Skelton H. Histologic features in primary cutaneous squamous cell carcinomas in immunocompromised patients focusing on organ transplant patients. Dermatol Surg 2004; 30:634–641.PubMedCrossRefGoogle Scholar
  78. 78.
    Harwood CA, Proby CM, McGregor JM, Sheaff MT, Leigh IM, Cerio R. Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J Am Acad Dermatol 2006; 54:290–300.PubMedCrossRefGoogle Scholar
  79. 79.
    Stelow EB, Skeate R, Wahi MM, Langel D, Jessurun J. Invasive cutaneous verruco-cystic squamous cell carcinoma. A pattern commonly present in transplant recipients. Am J Clin Pathol 2003; 119:807–810.Google Scholar
  80. 80.
    Cassarino DS, Derienzo DP, Barr RJ. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification. Part one. J Cutan Pathol 2006; 33:191–206.CrossRefGoogle Scholar
  81. 81.
    Cassarino DS, Derienzo DP, Barr RJ. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification. Part two. J Cutan Pathol 2006; 33:261–279.CrossRefGoogle Scholar
  82. 82.
    Kane CL, Keehn CA, Smithberger E, Glass LF. Histopathology of cutaneous squamous cell carcinoma and its variants. Semin Cutan Med Surg 2004; 23:54–61.PubMedCrossRefGoogle Scholar
  83. 83.
    Schwartz RA. Keratoacanthoma: a clinico-pathologic enigma. Dermatol Surg 2004; 30:326–333PubMedCrossRefGoogle Scholar
  84. 84.
    Rinker MH, Fenske NA, Scalf LA, Glass LF. Histologic variants of squamous cell carcinoma of the skin. Cancer Control 2001; 8:354–363.PubMedGoogle Scholar
  85. 85.
    Kurzen H, Zeier M, Zelger B, Hartschuh W. Unusual spindle cell squamous carcinoma in a renal transplant patient. Acta Dermatol Venereol 2004; 84:61–64.CrossRefGoogle Scholar
  86. 86.
    Lohmann CM, Solomon AR. Clinicopathologic variants of cutaneous squamous cell carcinoma. Adv Anat Pathol 2001; 8:27–36.PubMedCrossRefGoogle Scholar
  87. 87.
    Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47:1–17.PubMedCrossRefGoogle Scholar
  88. 88.
    Veness MJ, Quinn DI, Ong CS, Keogh AM, Macdonald PS, Cooper SG, Morgan GW. Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience. Cancer 1999; 85:1758–1764.PubMedCrossRefGoogle Scholar
  89. 89.
    Martinez JC, Otley CC, Stasko T, Euvrard S, Brown C, Schanbacher CF, Weaver AL; Transplant-Skin Cancer Collaborative. Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study. Arch Dermatol 2003; 139:301–306.PubMedCrossRefGoogle Scholar
  90. 90.
    Lindelof B, Jarnvik J, Ternesten-Bratel A, Granath F, Hedblad MA. Mortality and clinicopathological features of cutaneous squamous cell carcinoma in organ transplant recipients: a study of the Swedish cohort. Acta Dermatol Venereol 2006; 86:219–222.CrossRefGoogle Scholar
  91. 91.
    Preciado DA, Matas A, Adams GL. Squamous cell carcinoma of the head and neck in solid organ transplant recipients. Head Neck 2002; 24:319–325.PubMedCrossRefGoogle Scholar
  92. 92.
    Carucci JA, Martinez JC, Zeitouni NC, Christenson L, Coldiron B, Zweibel S, Otley CC. In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management, and outcome in a series of 21 patients. Dermatol Surg 2004; 30:651–655.PubMedCrossRefGoogle Scholar
  93. 93.
    Stasko T, Brown MD, Carucci JA, Euvrard S, Johnson TM, Sengelmann RD, Stockfleth E, Tope WD; International Transplant-Skin Cancer Collaborative; European Skin Care in Organ Transplant Patients Network. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg 2004; 30:642–650.PubMedCrossRefGoogle Scholar
  94. 94.
    Weinberg AS, Ogle CA, SHIM EK. Metastatic cutaneous squamous cell carcinoma: an update. Dermatol Surg 2007; 33: 885–889.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Anna Belloni Fortina
    • 1
  • Stefano Piaserico
    • 1
  • Mauro Alaibac
    • 1
  • Andrea Peserico
    • 1
  1. 1.Unit of DermatologyUniversity of PadovaPadovaItaly

Personalised recommendations